GPhC publishes anonymised individual results for pharmacists’ registration assessment
Source: General Pharmaceutical Council (GPhC)
The professional regulator for pharmacists has published the individual candidate results of graduates who sat the June 2015 registration assessment on its website.
The candidates are not named, but users are able to discover the individual marks a person achieved in the open book paper and its calculations section, the mark for the closed book paper, the overall mark and whether the person passed or failed the assessment.
Candidates are listed under the name of their pharmacy school.
In a statement on its website, the General Pharmaceutical Council (GPhC) says the information is being released following a request from a member of the public and “as part of its commitment to share information about its core regulatory functions that may be useful to others”.
Publication of the information is the latest move by the GPhC to offer more insight into the assessment exam, which graduates need to pass in order to register and practise as a pharmacist.
In September 2015, it published the assessment paper pass rates of individual pharmacy schools for the first time. Similar data will be published in subsequent years.
A month earlier, again for the first time, the regulator’s independent board of assessors released questions from the June assessment, with advice about possible pitfalls and the kind of answers it was looking for from candidates.
That information was made public just weeks after candidates and some of their tutors complained that the questions were too difficult and failed to reflect current practice.
In 2015, the June assessment pass rate fell to 74% — the lowest for three years.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20069537
Recommended from Pharmaceutical Press
Pharmacy Registration Assessment Questions features over 400 closed book and calculation questions. With the registration exam having gone through a complete transformation in 2016, this volume has been developed around the new General Pharmaceutical Council (GPhC) guidelines.£32.00Buy now